Abstract
Considerable advances have been made in the last decade in devising and evaluating cell transplantation strategies for enhancing axon regeneration for patients with spinal cord trauma, and in achieving remyelination in chronic demyelinating diseases such as multiple sclerosis. Thus, a number of studies have established that transplantation of glial cells can have beneficial consequences in experimental models of spinal cord trauma and demyelination. In particular, in rats, it has been shown that implantation of Schwann cells or olfactory glial cells results in significant regeneration of axons across spinal cord transection sites and that this is associated with an improvement of locomotor function (Cheng et al ., 1997; Xu et al ., 1999; Ramon-Cueto et al ., 2000). A potential therapeutic superiority of olfactory glia over Schwann cells was demonstrated by experiments in which the number of regenerating axons …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.